Progress in the clinical development of investigational systemic agents for recurrent and metastatic nasopharyngeal carcinoma
{{output}}
Introduction: Nasopharyngeal carcinoma (NPC) remains an endemic disease in certain parts of the world, with many patients presenting with advanced disease on diagnosis. Chemotherapy had remained the standard of care with minimal ... ...
